1 |
SUNG H, FERLAY J, SIEGEL R L, et al.. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J. Clin., 2021, 71(3): 209-249.
|
2 |
POLISENO L, SALMENA L, ZHANG J, et al.. A coding-independent function of gene and pseudogene mRNAs regulates tumour biology[J]. Nature, 2010, 465(7301): 1033-1038.
|
3 |
WANG Y, HOU J, HE D, et al.. The emerging function and mechanism of cernas in cancer[J]. Trends Genet., 2016, 32(4): 211-224.
|
4 |
GUO X, LV X, RU Y, et al.. Circulating exosomal gastric cancer-associated long noncoding RNA1 as a biomarker for early detection and monitoring progression of gastric cancer: a multiphase study[J]. JAMA Surg., 2020, 155(7): 572-579.
|
5 |
YANG X Z, CHENG T T, HE Q J, et al.. LINC01133 as ceRNA inhibits gastric cancer progression by sponging miR-106a-3p to regulate APC expression and the Wnt/β-catenin pathway[J/OL]. Mol. Cancer., 2018, 17(1): 126[2021-11-02]. .
|
6 |
YUAN L, XU Z Y, RUAN S M, et al.. Long non-coding RNAs towards precision medicine in gastric cancer: early diagnosis, treatment, and drug resistance[J/OL]. Mol. Cancer, 2020, 19(1): 96[2021-11-02]. .
|
7 |
WANG C J, ZHU C C, XU J, et al.. The lncRNA UCA1 promotes proliferation, migration, immune escape and inhibits apoptosis in gastric cancer by sponging anti-tumor miRNAs[J]. Mol. Cancer, 2019, 18(1):115.
|
8 |
THRIFT A P, EL-SERAG H B. Burden of gastric cancer[J]. Clin. Gastroenterol. Hepatol., 2020, 18(3): 534-542.
|
9 |
ZHANG E, HE X, ZHANG C, et al.. A novel long noncoding RNA HOXC-AS3 mediates tumorigenesis of gastric cancer by binding to YBX1[J/OL]. Genome Biol., 2018, 19(1):154[2021-11-02]. .
|
10 |
ZHUO W, LIU Y, LI S, et al.. Long noncoding RNA GMAN, up-regulated in gastric cancer tissues, is associated with metastasis in patients and promotes translation of ephrin A1 by competitively binding GMAN-AS[J]. Gastroenterology, 2019, 156(3): 676-691.
|
11 |
NECULA L, MATEI L, DRAGU D, et al.. Recent advances in gastric cancer early diagnosis[J]. World J. Gastroenterol., 2019, 25(17): 2029-2044.
|
12 |
SHUAI Y, MA Z, LIU W, et al.. TEAD4 modulated LncRNA MNX1-AS1 contributes to gastric cancer progression partly through suppressing BTG2 and activating BCL2[J/OL]. Mol. Cancer., 2020, 19(1): 6[2021-11-02]. .
|
13 |
XU W, ZHOU G, WANG H, et al.. Circulating lncRNA SNHG11 as a novel biomarker for early diagnosis and prognosis of colorectal cancer[J]. Int. J. Cancer., 2020, 146(10): 2901-2912.
|
14 |
GU J, LI Y, FAN L, et al.. Identification of aberrantly expressed long non-coding RNAs in stomach adenocarcinoma[J]. Oncotarget, 2017, 8(30): 49201-49216.
|
15 |
LIU Y W, XIA R, LU K, et al. LincRNAFEZF1-AS1 represses p21 expression to promote gastric cancer proliferation through LSD1-mediated H3K4me2 demethylation[J/OL]. Mol. Cancer, 2017, 16(1): 39[2021-11-02]. .
|
16 |
SONG J, LIU Y, WANG T, et al.. MiR-17-5p promotes cellular proliferation and invasiveness by targeting RUNX3 in gastric cancer[J/OL]. Biomed. Pharmacother., 2020, 128: 110246[2021-11-02]. .
|
17 |
HUANG S, ZHANG X, GUAN B, et al.. A novel circular RNA hsa_circ_0008035 contributes to gastric cancer tumorigenesis through targeting the miR-375/YBX1 axis[J]. Am. J. Transl. Res., 2019, 11(4): 2455-2462.
|